can tirzepatide cause liver issues Effect of Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction‐Associated Steatotic Disease and Type 2 Diabetes Mellitus - Arai - 2025 - Hepatology Research Tirzepatide for Weight Loss (Fat
Description
Long-term use of GLP-1 medications may lead to a higher incidence of osteomalacia
At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk
Evidence suggests GLP-1 therapies may modestly lower blood pressure while improving cardiometabolic risk in patients with diabetes and hypertension.
3 ...
PlexusDx offers prescription-strength GLP-1 therapy tailored to your genetic profile
Evidence-based protocols
